The Globe and Mail reports in its Friday edition that Canada's life insurance industry is opposing proposed restrictions on exclusivity deals between pharmacies and insurers, which pharmacists argue are necessary to protect patient health. A triple bylined item led by Clare O'Hara writes that during a public consultation, the Canadian Life and Health Insurance Association stated these preferred pharmacy networks (PPNs) are essential for managing the rising costs of group benefit drug plans. PPNs came under review last year after a public outcry when Manulife Financial announced it was providing Loblaw's pharmacies the exclusive right to fill prescriptions on certain specialty medications. Manulife later cancelled the deal. The recent consultation, which closed on Monday, gathered input on potential Ontario regulations aimed at limiting insurance companies' use of PPN deals. Concerns were raised about PPNs limiting patient access to care and creating anti-competitive pressure in the pharmacy sector, while some argued that excessive regulation could hinder cost savings. Ontario Finance Minister spokesman Colin Blachar said the ministry is reviewing submissions and will collaborate with sector partners on next steps.